Kadimastem Stock Market Value
| KMSTF Stock | USD 2.63 0.10 3.95% |
| Symbol | Kadimastem |
Kadimastem 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kadimastem's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kadimastem.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Kadimastem on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Kadimastem or generate 0.0% return on investment in Kadimastem over 30 days. Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human ... More
Kadimastem Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kadimastem's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kadimastem upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 39.4 | |||
| Value At Risk | (14.09) | |||
| Potential Upside | 9.43 |
Kadimastem Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kadimastem's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kadimastem's standard deviation. In reality, there are many statistical measures that can use Kadimastem historical prices to predict the future Kadimastem's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.25) | |||
| Total Risk Alpha | (1.96) | |||
| Treynor Ratio | (10.22) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kadimastem's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kadimastem Backtested Returns
Kadimastem has Sharpe Ratio of -0.17, which conveys that the firm had a -0.17 % return per unit of risk over the last 3 months. Kadimastem exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kadimastem's Risk Adjusted Performance of (0.11), mean deviation of 4.44, and Standard Deviation of 7.25 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.12, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Kadimastem's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kadimastem is expected to be smaller as well. At this point, Kadimastem has a negative expected return of -1.29%. Please make sure to verify Kadimastem's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Kadimastem performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.14 |
Insignificant reverse predictability
Kadimastem has insignificant reverse predictability. Overlapping area represents the amount of predictability between Kadimastem time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kadimastem price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Kadimastem price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | -0.78 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Kadimastem lagged returns against current returns
Autocorrelation, which is Kadimastem pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kadimastem's pink sheet expected returns. We can calculate the autocorrelation of Kadimastem returns to help us make a trade decision. For example, suppose you find that Kadimastem has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kadimastem regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kadimastem pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kadimastem pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kadimastem pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Kadimastem Lagged Returns
When evaluating Kadimastem's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kadimastem pink sheet have on its future price. Kadimastem autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kadimastem autocorrelation shows the relationship between Kadimastem pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Kadimastem.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Kadimastem Pink Sheet
Kadimastem financial ratios help investors to determine whether Kadimastem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kadimastem with respect to the benefits of owning Kadimastem security.